VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Discontinuation of imatinib therapy after achieving a molecular response.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Discontinuation of imatinib therapy after achieving a molecular response.
Discontinuation of imatinib therapy after achieving a molecular response. Blood. 2004 Oct 01; 104(7):2204-5.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Benzamides
Female
Fusion Proteins, bcr-abl
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Piperazines
Polymerase Chain Reaction
Pyrimidines
Remission Induction
Time Factors
Treatment Outcome
authors with profiles
HAGOP M KANTARJIAN
JORGE E CORTES